Nihilent unveils nSEPIA Beta to turn emotional wellness into measurable science

nSEPIA aims to bring structure to an area long dominated by subjectivity

Nihilent launches nSEPIA Beta, introduces AI-driven emotional wellness platform

AI-powered platform uses real-time emotion scanning and personalised interventions to make emotional wellness measurable and actionable

Nihon Kohden launches Life Scope E7 patient monitoring platform in India

CDSCO-cleared BSM-5700 series targets ICU, NICU, ER, OR and digital health integration under ABDM

Amydis bags $2.5 million NIH grant to develop first eye test for key ALS biomarker

World First: Heart bypass without opening the chest achieved by NIH and Emory Team

Sinopia Biosciences scores NIH grant to supercharge AI-driven drug discovery

The funding will accelerate Sinopia’s data-driven drug discovery efforts

Mesoblast teams with NIH to launch pivotal trial of life-saving cell therapy in adults with severe aGvHD

The therapy -- Ryoncil (remestemcel-L-rknd) -- will be tested in adults with severe steroid-refractory acute graft-versus-host disease

NIH develops AI agent to improve accuracy of gene set analysis

The system, called GeneAgent, cross-checks its own initial predictions for accuracy against information from established, expert-curated databases

Roche receives USFDA’s priority review to Xolair for food allergies based on positive NIH Phase III study results

If approved, Xolair would be the first medicine to reduce allergic reactions to multiple foods following an accidental exposure

NIH and Exothera partner to produce GMP intranasal vaccine against SARS-CoV-2 for clinical phase I/II trial in Africa and US

NIH’s candidate is based on the Adenovirus 4 backbone, largely used as a vector candidate in HIV and influenza vaccine clinical trials